We welcome teams with a project within alternative proteins to join the innovation challenge. In particular, we are looking for projects that have a first version of a solution and are in need of scaling.
For the EMEA challenge, we welcome anyone from countries within Europe, Middle East or Africa. The team must be able to travel to Germany, Belgium, Switzerland or France (Schengen-region), during the period of May-June 2022 (expenses will be covered).
For the US challenge, we welcome anyone from the United States and the District of Columbia and Canada. The team must be able to travel to the US, during the period of 13 September – 12 November 2021 (expenses will be covered)
Participants will submit their projects on an online platform in a predefined template. To get access to the platform, participants must sign up using their email. The submission can be edited at any point of time until closing. One participant will be the primary sender of the project, with other team members indicated. Teams must be able to participate in the onsite visit.
In the first phase of project sharing, we will ask you to submit a general description of your project, incl. a summary, the problem/need they are targeting, a general description of the solution (without disclosing confidential information), the potential of the solution, and an outline of current scaling challenges.
The IP-rights will stay with the participating team. It is a possibility that the participating team and a partner company will enter a formal collaboration, but that will be negotiated on a case-by-case basis.
There is no requirement of giving up any IP or equity. The IP stays with the participating start-up and you are encouraged not to share any confidential information on the platform. Participants can at any point withdraw from the challenge, and there are no caveats of doing so.
All projects submitted on the platform will be reviewed and assessed by representatives from the partnering companies. The evaluation criteria include:
- Desirability: is the solution attractive for the end-user (by proposing a desirable alternative to existing solutions) ?
- Feasibility: how likely is it that the solution can be launched within a reasonable timeframe?
- Viability: does the solution propose a viable business opportunity?
- Uniqueness/novelty: how unique/novel is the solution
The IP stays with you in any case, and no equity is taken. Participants can at any point withdraw from the challenge, and there are no caveats of doing so.
You can find more information about the innovation challenge by signing up and logging on to the platform.
We welcome anyone from the US, Canada and Mexico with a project within alternative proteins to join the innovation challenge. In particular, we are looking for projects that have a first version of a solution and are in need of scaling. The team must be able to travel to the US, during the period of 13 September – 12 November 2021 (expenses will be covered)
Participants will submit their projects on an online platform in a predefined template. To get access to the platform, participants must sign up using their email. The submission can be edited at any point of time until closing on 4 August 2021. One participant will be the primary sender of the project, with other team members indicated.
In the first phase of project sharing, we will ask you to submit a general description of your project, incl. a summary, the problem/need they are targeting, a general description of the solution (without disclosing confidential information), the potential of the solution, and an outline of current scaling challenges.
There is no requirement of giving up any IP or equity. The IP stays with the participating start-up and you are encouraged to not share any confidential information on the platform. Participants can at any point withdraw from the challenge, and there are no caveats of doing so.
The IP-rights will stay with the participating team. It is a possibility that the participating team and a partner company will enter a formal collaboration, but that will be negotiated on a case-by-case basis.
All projects submitted on the platform will be reviewed and assessed by representatives from the partnering companies. The evaluation criteria include:
- Desirability: is the solution attractive for the end-user (by proposing a desirable alternative to existing solutions) ?
- Feasibility: how likely is it that the solution can be launched within a reasonable timeframe?
- Viability: does the solution propose a viable business opportunity?
- Uniqueness/novelty: how unique/novel is the solution?
The IP stays with you in any case, and no equity is taken. Participants can at any point withdraw from the challenge, and there are no caveats of doing so
You can find more information about the innovation challenge by signing up and logging on to the platform.
If you have read this far, we know you are serious about alternative protein sources and doing something to make a difference in the world.
Sign up